Form 4: Nuvation Bio Inc. Executive Acquires Shares and Stock Options
SEC Form 4 Filing
Dongfang Liu, Chief Medical Officer of Nuvation Bio Inc., reports acquisition of shares and stock options.
Summary
- On February 28, 2025, Dongfang Liu, the Chief Medical Officer of Nuvation Bio Inc., acquired 12,000 shares of Class A Common Stock.
- Liu also acquired stock options for 500,000 shares of Class A Common Stock at an exercise price of $1.97, expiring on February 27, 2035.
- The stock options vest as to 25% on the one-year anniversary of February 28, 2025, and then monthly over the following 36 months, contingent upon continuous service.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock and option awards to an executive. The vesting schedule and exercise price are typical.
Positives
- The acquisition of shares and stock options by a key executive could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the executive's increased stake in the company positively, as it aligns their interests with the company's success.
Key Dates
| Date | Description |
|---|---|
| May 17, 2024 | Acquisition of 3,000 shares under the Issuer's 2021 Employee Stock Purchase Plan. |
| November 19, 2024 | Acquisition of 3,000 shares under the Issuer's 2021 Employee Stock Purchase Plan. |
| February 28, 2025 | Date of transaction: Acquisition of 12,000 shares and grant of stock options for 500,000 shares. |
| February 28, 2026 | First vesting date for 25% of the stock options. |
| February 27, 2035 | Expiration date of the stock options. |
| March 04, 2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.